Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoid Urologic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07499700
What this trial is testing

A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

Who this might be right for
Minimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
Bio-Thera Solutions 192
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07233330
What this trial is testing

Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome，Idiopathic
Mario Negri Institute for Pharmacological Research 10
Post-approval studies (Phase 4)Study completedNCT01129284
What this trial is testing

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Who this might be right for
Treatment Resistant Nephrotic Syndrome
Columbia University 15
Testing effectiveness (Phase 2)Looking for participantsNCT07614477
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of EVER001 in Participants With Selected Proteinuric Glomerular Diseases

Who this might be right for
Minimal Change Disease (MCD)IgA Nephropathy (IgAN)Focal Segmental Glomerulosclerosis (FSGS)
Everest Medicines (China) Co.,Ltd. 45
Not applicableUnknownNCT03068572
What this trial is testing

Diagnostic Value of Linked Color Imaging for Minimal Change Esophagitis in Nonerosive Reflux Esophagitis and GERD

Who this might be right for
Gastroesophageal Reflux DiseaseMinimal Change DiseaseNon-Reflux Esophagitis
Affiliated Hospital to Academy of Military Medical Sciences 90
Not applicableNot Yet RecruitingNCT06315504
What this trial is testing

Circulating Factors in Nephrotic Syndrome

Who this might be right for
Nephrotic SyndromeMembranous NephropathyMinimal Change Disease+1 more
Iain Bressendorff 104
Large-scale testing (Phase 3)Active Not RecruitingNCT05914155
What this trial is testing

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome

Who this might be right for
Glomerulonephritis, MembranousNephrotic Syndrome，Idiopathic
Shoichi Maruyama MD PhD 88
Not applicableStudy completedNCT04075656
What this trial is testing

UrApp for Childhood Nephrotic Syndrome Management (Incident Cohort)

Who this might be right for
Idiopathic Nephrotic Syndrome
Emory University 58
Testing effectiveness (Phase 2)UnknownNCT03970577
What this trial is testing

RItuximab From the FIRst Episode of Idiopathic Nephrotic Syndrome

Who this might be right for
Minimal Change Nephrotic Syndrome (MCNS)
Assistance Publique - Hôpitaux de Paris 148
Large-scale testing (Phase 3)Study completedNCT04494438
What this trial is testing

Rituximab for Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic Syndrome
Istituto Giannina Gaslini 30
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Large-scale testing (Phase 3)Study completedNCT01197040
What this trial is testing

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 117
Testing effectiveness (Phase 2)Study completedNCT04034316
What this trial is testing

Reduce Immunosuppression With Atmp in NS ChildrEn

Who this might be right for
Nephrotic Syndrome in ChildrenSteroid-Dependent Nephrotic SyndromeIdiopathic Nephrotic Syndrome
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Testing effectiveness (Phase 2)Looking for participantsNCT07710157
What this trial is testing

A Trial to Assess the Efficacy and Safety of Obinutuzumab in Treating Adults With Minimal Change Disease (MCD)

Who this might be right for
Minimal Change Disease (MCD)
Medical University Innsbruck 48
Not applicableUnknownNCT03786263
What this trial is testing

CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study

Who this might be right for
Nephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome，Idiopathic
University of Calgary 400
Large-scale testing (Phase 3)Study completedNCT02818738
What this trial is testing

Efficiency of Levamisole for Maintaining Remission After the First Flare of Steroid Sensitive Nephrotic Syndrome in Children

Who this might be right for
First Manifestation of Steroid Sensitive Nephrotic Syndrome
Assistance Publique - Hôpitaux de Paris 86
Large-scale testing (Phase 3)UnknownNCT02896270
What this trial is testing

Valproic Acid for Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease
Universitair Ziekenhuis Brussel 15
Not applicableLooking for participantsNCT05583942
What this trial is testing

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 10
Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Next Page